NeuBase Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

COMMON STOCK OPTIONS (Details Narrative)

COMMON STOCK OPTIONS (Details Narrative) - USD ($)											12 Months Ended
COMMON STOCK OPTIONS (Details Narrative) - USD ($)	Mar. 10, 2015	Mar. 03, 2015	Mar. 01, 2015	Feb. 13, 2015	Jan. 06, 2015	Sep. 05, 2014	Jul. 24, 2014	Feb. 03, 2014	May. 17, 2013	Apr. 30, 2013	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013	Feb. 24, 2015	Feb. 11, 2015	Feb. 06, 2015	Oct. 29, 2014	May. 30, 2014	Oct. 02, 2013
Fair Value assumptions:
Stock price														$ 9.78	$ 6.75	$ 7	$ 7.19	$ 8.52	$ 7.96
Options granted											1,106,000	915,000	233,334
Exercise price, grants											$ 9.04	$ 9.29	$ 4.71
Unamortized option expense											$ 4,462,655	$ 3,161,447	$ 1,112,000
Intrinsic value of awards											$ 595,000
Stock Option [Member]
Fair Value assumptions:
Dividend yield											0.00%
Options granted	546,000	100,000	200,000	120,000	140,000
Exercise price, grants	$ 10.14	$ 9.78	$ 7.06	$ 7.68	$ 8.19
Fair value of options granted	$ 2,700,392	$ 509,845	$ 1,128,604		$ 529,252
Number of options vested in period	136,500	25,000	30,000	50,000	15,000
Number of options nonvested	409,500	75,000	90,000	150,000	105,000
Percent of options vesting at each anniversary	25.00%	25.00%	25.00%	25.00%	25.00%
Stock based compensation expense					$ 18,902
Intrinsic value of awards			$ 120,000	$ 250,000
Stock Option [Member] \| 02/03/14 [Member]
Fair Value assumptions:
Options granted								500,000
Exercise price, grants								$ 10.11
Fair value of options granted								$ 1,954,384
Vesting terms								125,000 vested upon issuance and the remaining 375,000 vest in 25 percent tranches on each anniversary of grant
Number of options vested in period								125,000			125,000	125,000	0
Number of options nonvested								375,000
Percent of options vesting at each anniversary								25.00%
Stock based compensation expense											$ 488,596	$ 814,327	$ 0
Stock Option [Member] \| 07/24/14 [Member]
Fair Value assumptions:
Options granted							355,000
Exercise price, grants							$ 8.39
Fair value of options granted							$ 1,661,682
Vesting terms							88,750 vested upon issuance and the remaining 266,250 vest in 25 percent tranches on each anniversary of grant.
Number of options vested in period							88,750				78,750	88,750	0
Number of options nonvested							266,250
Percent of options vesting at each anniversary							25.00%
Stock based compensation expense											$ 332,957	$ 610,436	$ 0
Stock Option [Member] \| 09/05/14 [Member]
Fair Value assumptions:
Options granted						60,000
Exercise price, grants						$ 7.77
Fair value of options granted						$ 250,683
Vesting terms						88,750 vested upon issuance and the remaining 266,250 vest in 25 percent tranches on each anniversary of grant.
Number of options vested in period						15,000					15,000	15,000	0
Number of options nonvested						45,000
Percent of options vesting at each anniversary						25.00%
Stock based compensation expense											$ 62,671	$ 86,957	$ 0
Stock Option [Member] \| 01/06/15 [Member]
Fair Value assumptions:
Number of options vested in period											35,000	0	0
Stock based compensation expense											$ 275,563	$ 0	$ 0
Stock Option [Member] \| 02/13/15 [Member]
Fair Value assumptions:
Number of options vested in period											50,000	0	0
Stock based compensation expense											$ 167,360	$ 0	$ 0
Stock Option [Member] \| 03/01/15 [Member]
Fair Value assumptions:
Number of options vested in period											50,000	0	0
Stock based compensation expense											$ 456,420	$ 0	$ 0
Stock Option [Member] \| 03/03/15 [Member]
Fair Value assumptions:
Number of options vested in period											0	0	25,000
Stock based compensation expense											$ 0	$ 0	$ 350,519
Stock Option [Member] \| 03/10/15 [Member]
Fair Value assumptions:
Number of options vested in period											136,000	0	0
Stock based compensation expense											$ 1,068,905	$ 0	$ 0
Stock Option [Member] \| Lower Range [Member[
Fair Value assumptions:
Stock price											$ 1.20
Exercise Price											$ 1.50
Risk free interest rate											0.68%
Volatility rate											81.00%
Stock Option [Member] \| Upper Range [Member]
Fair Value assumptions:
Expected term											5 years
Risk free interest rate											2.60%
Volatility rate											277.00%
Employee Stock Option [Member] \| Upper Range [Member]
Fair Value assumptions:
Stock price											$ 10.11
Exercise Price											$ 10.11
Stock Options 04/30/13 [Member] \| Board Member [Member]
Fair Value assumptions:
Options granted										116,667
Fair value of options granted, per share										$ 4.59
Vesting terms										29,167 vested upon issuance and the remaining 87,500 vest in 33 percent tranches on the next three anniversary dates.
Number of options vested in period										29,167	29,167	58,333	29,167
Number of options nonvested										87,500
Percent of options vesting at each anniversary										33.00%
Stock based compensation expense											$ 133,813	$ 133,690	$ 189,852
Stock Options 05/17/13 [Member] \| Board Member [Member]
Fair Value assumptions:
Options granted									116,667
Fair value of options granted, per share									$ 4.50
Vesting terms									29,167 vested upon issuance and the remaining 87,500 vest in 33 percent tranches on the next three anniversary dates.
Number of options vested in period									29,167		29,167	58,333	29,167
Number of options nonvested									87,500
Percent of options vesting at each anniversary									33.00%
Stock based compensation expense											$ 131,285	$ 131,165	$ 180,156